MGMT and glioblastoma: for example, showed a substantial correlation between it and temozolomide responsiveness (Binabaj et al., 2018) and Later meta-analyses have confirmed that in glioblastoma patients after alkylating chemotherapy, MGMT methylation is associated with better overall and progression-free survival (Zhang et al., 2013).